Processa Pharmaceuticals Stock Forward View
| PCSA Stock | USD 3.00 0.14 4.46% |
Processa Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Processa Pharmaceuticals stock prices and determine the direction of Processa Pharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Processa Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Processa Pharmaceuticals' share price is approaching 38 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Processa Pharmaceuticals, making its price go up or down. Momentum 38
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.06) | EPS Estimate Current Year (10.75) | EPS Estimate Next Year (3.75) | Wall Street Target Price 25 | EPS Estimate Current Quarter (0.08) |
Using Processa Pharmaceuticals hype-based prediction, you can estimate the value of Processa Pharmaceuticals from the perspective of Processa Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Processa Pharmaceuticals on the next trading day is expected to be 2.24 with a mean absolute deviation of 0.50 and the sum of the absolute errors of 30.28. Processa Pharmaceuticals after-hype prediction price | USD 3.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Processa Pharmaceuticals to cross-verify your projections. Processa Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Processa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Processa using various technical indicators. When you analyze Processa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Processa Pharmaceuticals Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Processa Pharmaceuticals' financial statements to predict how it will affect future prices.
Cash | First Reported 2012-09-30 | Previous Quarter 6.9 M | Current Value 6.3 M | Quarterly Volatility 6 M |
Processa Pharmaceuticals Naive Prediction Price Forecast For the 3rd of February
Given 90 days horizon, the Naive Prediction forecasted value of Processa Pharmaceuticals on the next trading day is expected to be 2.24 with a mean absolute deviation of 0.50, mean absolute percentage error of 0.45, and the sum of the absolute errors of 30.28.Please note that although there have been many attempts to predict Processa Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Processa Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Processa Pharmaceuticals Stock Forecast Pattern
| Backtest Processa Pharmaceuticals | Processa Pharmaceuticals Price Prediction | Research Analysis |
Processa Pharmaceuticals Forecasted Value
In the context of forecasting Processa Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Processa Pharmaceuticals' downside and upside margins for the forecasting period are 0.03 and 21.11, respectively. We have considered Processa Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Processa Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Processa Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 117.3111 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.4965 |
| MAPE | Mean absolute percentage error | 0.1046 |
| SAE | Sum of the absolute errors | 30.2842 |
Predictive Modules for Processa Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Processa Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Processa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Processa Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Processa Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Processa Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Processa Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Processa Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Processa Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Processa Pharmaceuticals' historical news coverage. Processa Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.15 and 21.73, respectively. We have considered Processa Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Processa Pharmaceuticals is abnormally volatile at this time. Analysis and calculation of next after-hype price of Processa Pharmaceuticals is based on 3 months time horizon.
Processa Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Processa Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Processa Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Processa Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 18.87 | 0.16 | 0.10 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.00 | 3.00 | 0.00 |
|
Processa Pharmaceuticals Hype Timeline
Processa Pharmaceuticals is at this time traded for 3.00. The entity has historical hype elasticity of -0.16, and average elasticity to hype of competition of -0.1. Processa is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.36%. %. The volatility of related hype on Processa Pharmaceuticals is about 6506.9%, with the expected price after the next announcement by competition of 2.90. The company has price-to-book ratio of 1.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Processa Pharmaceuticals recorded a loss per share of 28.75. The entity last dividend was issued on the 23rd of December 2019. The firm had 1:25 split on the 17th of December 2025. Given the investment horizon of 90 days the next projected press release will be in about 8 days. Check out Historical Fundamental Analysis of Processa Pharmaceuticals to cross-verify your projections.Processa Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Processa Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Processa Pharmaceuticals' future price movements. Getting to know how Processa Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Processa Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BCTX | Briacell Therapeutics Corp | (1.35) | 8 per month | 0.00 | (0.09) | 13.96 | (9.09) | 98.43 | |
| CRIS | Curis Inc | (0.11) | 8 per month | 0.00 | (0.14) | 9.60 | (8.13) | 33.70 | |
| ENTO | Entero Therapeutics | (0.23) | 6 per month | 0.00 | (0.01) | 16.86 | (17.06) | 39.61 | |
| LPTX | Leap Therapeutics | 0.01 | 9 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| PALI | Palisade Bio | (0.19) | 9 per month | 6.68 | 0.01 | 13.86 | (10.26) | 31.35 | |
| HOTH | Hoth Therapeutics | 0.02 | 6 per month | 0.00 | (0.20) | 4.81 | (5.79) | 14.85 | |
| MBRX | Moleculin Biotech | (0.50) | 9 per month | 0.00 | (0.21) | 9.37 | (11.73) | 41.63 | |
| ATHA | Athira Pharma | (0.54) | 8 per month | 4.13 | 0.05 | 6.70 | (8.06) | 71.83 | |
| ALLR | Allarity Therapeutics | (0.11) | 9 per month | 0.00 | (0.08) | 7.07 | (9.02) | 19.82 | |
| CTXR | Citius Pharmaceuticals | 0.1 | 9 per month | 0.00 | (0.16) | 10.59 | (9.49) | 38.23 |
Other Forecasting Options for Processa Pharmaceuticals
For every potential investor in Processa, whether a beginner or expert, Processa Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Processa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Processa. Basic forecasting techniques help filter out the noise by identifying Processa Pharmaceuticals' price trends.Processa Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Processa Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Processa Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Processa Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Processa Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Processa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Processa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Processa Pharmaceuticals stock market strength indicators, traders can identify Processa Pharmaceuticals entry and exit signals to maximize returns.
Processa Pharmaceuticals Risk Indicators
The analysis of Processa Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Processa Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting processa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.46 | |||
| Standard Deviation | 18.46 | |||
| Variance | 340.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Processa Pharmaceuticals
The number of cover stories for Processa Pharmaceuticals depends on current market conditions and Processa Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Processa Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Processa Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Processa Pharmaceuticals Short Properties
Processa Pharmaceuticals' future price predictability will typically decrease when Processa Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Processa Pharmaceuticals often depends not only on the future outlook of the potential Processa Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Processa Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 122.4 K | |
| Cash And Short Term Investments | 1.2 M |
Check out Historical Fundamental Analysis of Processa Pharmaceuticals to cross-verify your projections. For information on how to trade Processa Stock refer to our How to Trade Processa Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Processa Pharmaceuticals. Anticipated expansion of Processa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Processa Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Processa Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Processa Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Processa Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Processa Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Processa Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Processa Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.